Market Tracker

05/29 6:02pm ET

Incyte Corp (NASDAQ:INCY)

110.15
Delayed Data
As of May 29
 +2.01 / +1.86%
Today’s Change
43.86
Today|||52-Week Range
111.93
+50.66%
Year-to-Date

Today’s Trading

Previous close108.14
Today’s open107.90
Day’s range107.06 - 111.08
Volume1,246,321
Average volume (3 months)1,180,990
Market cap$19.7B
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+48.21%
Earnings growth (this year)+7.33%
Earnings growth (next 5 years)+219.00%
Revenue growth (last year)+44.10%
P/E ratioNM
Price/Sales24.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-1.82-1.43%
----
HSPHospira Inc-0.02-0.02%
MNKMallinckrodt Plc-0.74-0.57%
Data as of 4:02pm ET, 05/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$511.5M
Annual profit (last year)-$48.5M
Net profit margin-9.48%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts